Background-The cAMP-elevating A 2b adenosine receptor (A 2b AR) controls inflammation via its expression in bone marrow cells. Methods and Results-Atherosclerosis induced by a high-fat diet in apolipoprotein E-deficient mice was more pronounced in the absence of the A 2b AR. Bone marrow transplantation experiments indicated that A 2b AR bone marrow cell signals alone were not sufficient to elicit this effect. Intriguingly, liver expression of the A 2b AR in wild-type mice was vastly augmented by a high-fat diet, raising the possibility that this upregulation is of functional significance. A 2b AR genetic ablation led to elevated levels of liver and plasma cholesterol and triglycerides and to fatty liver pathology typical of steatosis, assessed by enzymatic assays and analysis of liver sections. Western blotting and quantitative polymerase chain reaction revealed elevated expression of the following molecules in the liver of A 2b AR-null mice: the transcription factor sterol regulatory element binding protein-1 (SREBP-1) and its 2 downstream targets and regulators of lipogenesis, acetyl CoA carboxylase and fatty acid synthase. Pharmacological activation or inhibition of A 2b AR in primary hepatocytes confirmed the regulation of SREBP-1 by this receptor. A 2b AR-mediated changes in cAMP were found to regulate levels of the transcriptionally active form of SREBP-1. Finally, adenovirally mediated restoration of the A 2b AR in the liver of A 2b AR-null mice reduced the lipid profile and atherosclerosis. Similarly, in vivo administration of the A 2b AR ligand BAY 60-6853 in control mice on a high-fat diet reduced the lipid profile and atherosclerosis. Conclusion-This study provides the first evidence that the A 2b AR regulates liver SREBP-1, hyperlipidemia, and atherosclerosis, suggesting that this receptor may be an effective therapeutic target. (Circulation. 2012;125:354-363.)
A therosclerosis is a major contributor to cardiovascularrelated mortality. Diets rich in cholesterol and saturated fats, lack of exercise, smoking, and high blood pressure all contribute to the development of atherosclerosis. Numerous genes have been identified in relation to the development of this pathology, including those involved in the synthesis and clearance of cholesterol, 1 inflammation, 2 and altered glucose metabolism. 3 
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Extracellular adenosine is generated upon stress 4 or inflammation 5 and acts on 4 different G-protein-coupled receptors, historically classified as adenylyl cyclase inhibiting (A 1 and A 3 ) or activating (A 2a and A 2b ). Adenosine can regulate inflammation 6 -8 and metabolic processes involved in insulin homeostasis, 9, 10 glucose metabolism, [11] [12] [13] lipolysis, 14, 15 and cholesterol synthesis. 16 Of the 4 adenosine receptors, the A 2b AR has the lowest affinity for adenosine. 17 It was not until the generation of the A 2b AR knockout (KO)/␤-galactosidase knock-in model that the importance of this receptor was clearly elucidated in vivo. 8 ␤-Galactosidase expression in these mice indicated that in wild-type mice the A 2b AR exhibits widespread expression in the vasculature and inflammatory cells such as macrophages. Plasma analysis suggested a mildly enhanced inflammatory profile with elevated interleukin-6 and tumor necrosis factor-␣. These 2 cytokines were further augmented upon challenge with bacterial lipopolysaccharides, and this elevation in cytokine levels was dependent on A 2b AR bone marrow cell signals. Further analysis of the vasculature of this KO model showed elevated expression of vascular adhesion molecules such as P-selectin, E-selectin, and intracellular adhesion molecule-1, as well as an increased adhesion of leukocytes to endothelial cells. 8 Additionally, in a model representative of human restenosis after angioplasty, A 2b AR KO mice showed increased lesion formation, an effect that was also dependent on A 2b AR bone marrow cell signals. 18 Given these observations, we sought to elucidate the role of A 2b AR in atherosclerosis induced by a Western high-fat diet (HFD) . For that purpose, we generated a double-KO (dKO) model of A 2b AR and apolipoprotein E (ApoE) genes and exposed the mice to a Western diet. Ablation of the A 2b AR led to an elevation of plasma lipids and concomitant augmentation of the atherosclerotic profile. The pathophysiology of this hyperlipidemia and the consequent increase in atherosclerosis were due in part to altered sterol regulatory element binding protein-1 (SREBP-1) signaling in the liver.
Methods
Animals C57BL/6J mice and ApoE KO mice were purchased from The Jackson Laboratory. A 2b AR, ApoE dKO mice were generated by breeding the A 2b AR KO, ␤-galactosidase knock-in 8 and the ApoE KO mouse models. All experimental groups were on a C57BL/6J strain background, confirmed by polymerase chain reaction-based gene marker analysis with MAX-BAX (The Charles River Laboratories). For this study, male mice were used unless specified otherwise. ApoE KO and dKO mice were matched for strain, sex, and age. All animals received humane care in accordance with guidelines approved by the Institutional Animal Care and Use Committee of the Boston University School of Medicine.
Diets
In all experiments, male mice at 12 weeks of age were subjected to either a regular chow diet (Teklad; catalog No. TD2918) or a Western diet (Teklad; catalog No. TD88137) for 8, 12, or 16 weeks. Before tissue or blood collection, mice were starved for 16 hours, unless otherwise indicated.
Isolation and Treatment of Primary Hepatocytes
Hepatocytes from mice on HFD were isolated as previously described, 19 and treated with pharmacological reagents as indicated (Details are provided in the online-only Data Supplement).
cAMP Measurements
Liver lobes were homogenized in 0.1N HCl, and 100 L homogenate was loaded onto the plates and probed for cAMP according to the manufacturer's protocol. Hepatocytes were also subjected to cAMP determination (Details are provided in the online-only Data Supplement).
Aortic Lesion Analysis
For Oil Red O staining, aortas were isolated after blood collection by heart puncture and analyzed as described before. 20 Images were analyzed with the National Institutes of Health software ImageJ (version 1.62; http://rsb.info.nih.gov/ij/).
Immunohistochemistry and Osmium Tetroxide Staining
Brachiocephalic arteries were cryoembedded, and sections were analyzed with F4/80 macrophage antibody (AbD Serotec) as described previously. 18 Pictures were taken with an Olympus IX70 microscope. Lipid distribution in the liver was determined in cryoembedded sections stained with OsO 4 as described previously. 21 Briefly, cryosections of the embedded organ were stained with 0.1% OsO 4 in Palade buffer (0.03 mol/L sodium barbital, 0.03 mol/L sodium acetate buffer, 0.07 mol/L potassium chloride, pH 7.4) for 10 minutes. The final concentration of 0.1% OsO 4 was achieved by dissolving 1 g OsO 4 in 100 mL barbital buffer. Pictures were taken with a Nikon Eclipse 50i microscope.
␤-Galactosidase Staining
Mice were anesthetized with isoflurane; blood was removed by heart puncture; and a small piece of the liver lobe was excised and placed in 2% paraformaldehyde for 2 hours followed by incubation with 1ϫ PBS supplemented with 2 mmol/L MgCL 2 for 1 hour. The piece was then stained overnight with x-galactosidase as described previously. 8
Quantitative Polymerase Chain Reaction
RNA was isolated with the RNeasy mini kit (Qiagen; catalog No. 74104), and cDNA was generated with the Superscript II kit (Invitrogen; catalog No. 18064 -22) according to manufacturer's instructions. mRNA levels of selected genes were quantified with Applied Biosystems TaqMan primers (details are provided in the online-only Data Supplement).
Western Blots
Liver or hepatocyte proteins were isolated with radioimmunoprecipitation assay buffer. 8 Proteins were resolved on 8% to 10% SDS gels and probed with acetyl coenzyme-A carboxylase-␣ (ACC␣; Cell Signaling), fatty acid synthase (FAS; Novus Biologicals), SREBP-1 (Santa Cruz), and ␤-actin (Sigma) antibodies.
Cholesterol and Triglyceride Analyses
Plasma or liver was analyzed for triglycerides and cholesterol with the Triglyceride Determination Kit (Sigma) and Infinity Cholesterol Reagent Kit (Thermo Scientific) according to manufacturers' instructions. Liver cholesterol was measured as described previously. 22 Liver triglyceride isolation was done with ethanolic KOH as described previously. 23 The concentration of triglycerides ([TG]) was calculated with the following formula: [TG]ϭ[glycerol (mg/dL)ϫ10 (L loaded)ϫ(415/200)ϫ0.012 (dL)]/liver weight (g).
Fast Protein Liquid Chromatography
Plasma was resolved by fast protein liquid chromatography in 25 fractions as described previously. 24, 25 Each fraction was analyzed for triglycerides and cholesterol as described above. 24, 25 
Thin-Layer Chromatography
Primary hepatocytes plated at 1ϫ10 5 per 12-well plate were starved overnight and then incubated for 24 hours with 5 Ci sodium-[1,2-14 C]-acetate (Perkins Elmer) as described previously 26 (Details are provided in the online-only Data Supplement).
Adenoviral Injection
Human A 2b AR cDNA (cDNA.org; catalog No. ADRA2B0000) was engineered in an adenovirus (AdV) system with a green fluorescent protein (GFP) marker under cytomegalovirus (CMV) promoter (CMV-A 2b AR GFP-AdV vector). As a control, a vector containing only GFP was used (CMV-GFP-AdV vector). Both of the adenoviral constructs were cloned, replicated, and titered in vivo by Vector Biolabs (Philadelphia, PA). dKO mice were injected in the tail vein with 2ϫ10 9 viral particles as described previously. 25 On the fourth day after injection, mice were starved for 6 hours, and plasma and livers were collected for analysis.
BAY 60-6583 Injection
Mice were injected intraperitoneally every third day for 12 weeks with BAY 60-6583 (2 g/g mouse dissolved in vehicle: 10% ethanol, 50% PEG-400, 40% water 27 ) or with an equal volume of vehicle. At completion, mice were starved for 16 hours, reinjected at 14.5 hours with BAY 60-6583 or vehicle, and collected for analysis.
Statistical Analysis
The data from each experiment are expressed as meanϮSD. Statistical comparison was done with the 2-tailed exact (Mann Whitney) t test, considered significant when the medians were different at PՅ0.05. When appropriate and as indicated, we used 1-tailed ANOVA followed by the Bonferroni multiple-comparison test. All statistical analyses were performed with GraphPad Prism5 software.
Results

The A 2b AR Protects Against Atherosclerosis
Because wild-type mice on a C57BL/6J background do not develop atherosclerosis of all phases along the aortic tree, 1 the conventional approach to study this pathology is on an ApoE-null background. 28, 29 We monitored atherosclerosis in a mouse model in which the A 2b AR was eliminated from ApoE KO mice (A 2b AR, ApoE dKO). Comparison of ApoE KO and A 2b AR, ApoE dKO mice revealed that A 2b AR was protective against lipid plaque formation induced by 8 weeks of a Western HFD in male mice (20 weeks old at collection time). This was revealed by lipid staining with Oil Red O of the entire aorta and the aortic arch ( Figure 1A and 1B) and hematoxylin and eosin staining of arterial tissue sections to determine lesion formation ( Figure 1C and 1D). After 16 weeks on HFD diet, the lipid plaques measured by Oil Red O became saturated in the aortas of both mouse lines. However, the differences in aortic arch lesions were still statistically significant in the experimental groups ( Figure IA and IB in the online-only Data Supplement). An increase in lipid plaques was also noticed in dKO mice (28- week-old mice) on a chow diet ( Figure IC and ID in the online-only Data Supplement). Of note, crude food consumption and body weights were similar in the 2 groups (data not shown).
The A 2b AR Controls the Plasma Lipid Profile
Consistent with the pathogenesis of atherosclerosis, A 2b AR, ApoE dKO mice harbored increased plasma levels of cholesterol and triglycerides after 8 weeks ( Figure 2A Fast protein liquid chromatography of the plasma showed that the increased amount of lipid is concentrated in the region corresponding to very-low-density lipoprotein ( Figure 2B and 2C). In addition, A 2b AR KO mice (expressing the ApoE gene) had augmented lipid levels after HFD as compared with wild-type mice ( Figure IIB in the online-only Data Supplement), but the absolute levels in both groups were much lower than the atherosclerosis-inducing levels in ApoE-null mice 30, 31 (compare with Figure 2A ). Elevation of lipids was also observed in dKO mice on a regular chow diet compared with ApoE KO mice on a regular chow diet, again to a lower extent than under an HFD ( Table I in Figure 2A ). Together, these data point to a role for the A 2b AR in regulating lipid levels, regardless of ApoE expression or the type of diet. 
Bone Marrow-Derived Signals From the A 2b AR Do Not Affect Atherosclerosis or the Lipid Profile
Macrophages express high levels of the A 2b AR, which controls the synthesis of inflammatory cytokines such as tumor necrosis factor-␣. 8 Tumor necrosis factor-␣, in turn, was shown to affect lipid synthesis 32 and atherosclerosis. 33 To determine the contribution of A 2b AR bone marrow signals to atherosclerosis and to the lipid profile, bone marrow cells derived from A 2b AR, ApoE dKO mice were transplanted into ApoE KO irradiated male mice. The results of this experiment indicate that A 2b AR bone marrow cell signals alone are insufficient to elicit effects on the progression of atherosclerosis or on plasma lipid accumulation after HFD consumption ( Figure 3 ). This is contrary to the protective effect of A 2b AR bone marrow signals on vascular lesion development in a model reminiscent of restenosis. 18 Effective transplantation was evaluated as described previously 8 ( Figure III in the online-only Data Supplement).
The A 2b AR Is Upregulated in the Liver Under an HFD and Affects Liver Cholesterol and Triglyceride Levels
The liver is the major organ responsible for endogenous cholesterol and triglyceride synthesis. Hence, we first sought to determine the level of expression of the A 2b AR in this organ and its lipogenic ability. A 2b AR KO mice carry the ␤-galactosidase gene knocked in under the control of the A 2b AR gene promoter. 8 Previously, we reported that ␤-galactosidase staining of liver isolated from 12-week-old A 2b AR KO mice on a regular diet showed no significant signal except in the vasculature. 8 Here, we show that an HFD robustly induces A 2b AR gene expression in the entire organ, as illustrated by the blue color of the ␤-galactosidase staining ( Figure 4A ). Furthermore, examination by quantitative polymerase chain reaction of the endogenous levels of the A 2b AR confirmed the increased expression of this receptor in the liver after an HFD ( Figure 4B ). Additionally, elevation of lipid content after HFD was significantly higher in the livers of mice lacking the A 2b AR ( Figure 4C ). Lipid staining of liver sections showed that lipid accumulation increased in the A 2b AR-null mice after an HFD, resulting in a histopathology typical of steatosis ( Figure 4D) . Consistent with the observed liver steatosis, aspartate transaminase activity levels were increased in the plasma of mice lacking A 2b AR after 8 weeks on HFD ( Figure IVA 
A 2b AR Activation/Deletion Regulates SREBP-1 and Triglyceride and Cholesterol Synthesis in Liver and Primary Hepatocytes
To gain insight into the mechanisms by which A 2b AR ablation affects liver lipid synthesis after HFD, we used microarray analysis to measure gene expression in ApoE KO and dKO mice (limited repeats; data not shown). In our search for potential regulators of lipid synthesis, we noted that the mRNA level of the SREBP-1 is upregulated in the dKO mice compared with the ApoE KO mice. This was confirmed by quantitative polymerase chain reaction and Western blot analysis showing upregulation of the transcriptionally active form of SREBP-1 (68 kDa; Figure 5A and Figure V in the online-only Data Supplement). SREBP-1 is a transcription factor associated with regulation of genes such as ACC and FAS that are involved in lipogenesis. 34 As anticipated, the expression of ACC and FAS was elevated in livers from dKO mice ( Figure 5A ). Quantitative polymerase chain reaction also revealed that A 2b AR elimination selectively affected SREBP-1c mRNA levels in that levels of SREBP-1a were unchanged ( Figure 5B ).
To determine whether the effect of A 2b AR deletion on SREBP-1 is systemic or dependent on signals originating from hepatocytes, the levels of triglycerides and cholesterol were measured in primary hepatocytes from ApoE KO and dKO mice. We first confirmed that hepatocytes isolated from the livers of the ApoE KO mice express the A 2b AR and found that they do, consistent with the ␤-galactosidase staining of the whole liver in dKO mice ( Figure 4A and Figure VI in the online-only Data Supplement). Using 1,2-14 C-labeled acetate and thin layer chromatography, we showed that dKO cells have increased lipid synthesis ( Figure 5C ), similar to the observed liver profile ( Figure 4C ). Additionally, baseline cAMP levels in liver or hepatocytes isolated from mice lacking the A 2b AR were lower than in the corresponding control cells ( Figure 5D ). Relevant to our findings, previous studies have shown that cAMP inhibits the processing and thus, activation of SREBP-1 (68-kDa form). 35 Hepatocytes derived from ApoE-null mice (bearing normal A 2b AR) under the above-described HFD regimen were treated with an A 2b AR-specific antagonist, CVT-6883. 36 This resulted in attenuation of the A 2b AR agonist (BAY 60-6583 36 )-mediated increases in cAMP (Figure 5E , left) and upregulation of the mature form of SREBP-1 and of its downstream target, ACC ( Figure 5F, left) . CVT-6883 alone had no significant inhibitory effect on cAMP, as its influence is manifested mainly while blocking agonist activity and when adenylyl cyclase activity is high enough (Figure 5E , left panel). Regulation of cAMP and SREBP-1, and consequently of ACC, by BAY 60-6583 was not observed in the A 2b AR, ApoE dKO hepatocytes used as control ( Figure 5E and 5F, right). Of note, the A 2b AR-wild type (ApoE KO) or A 2b AR, ApoE dKO hepatocytes treated with a stable cAMP analog (8-bromo-cAMP) that permeates cells (note cAMP levels in Figure 5E ) had diminished levels of the transcriptionally active form of SREBP-1 ( Figure 5F ).
Since stimulation of the A 2b AR with BAY 60-6583 or inhibition with CVT-6883 affected the levels of cAMP and processed SREBP-1 in a manner consistent with cAMPmediated downregulation of active SREBP-1, we postulate that the mechanism by which the A 2b AR regulates SREBP-1 involves cAMP.
Restoration of the A 2b AR in the Liver and In Vivo Activation of This Receptor Reduced Plasma Lipids and Atherosclerotic Plaques
To examine the specific contribution of liver A 2b AR to the observed hyperlipidemia in vivo, the receptor was restored in the livers of the dKO mice by adenovirally mediated A 2b AR expression (A 2b AR-Ad). AdVs are known to infect primarily the liver for the first week after injection, with marginal targeting of other tissues 37 (also confirmed in our laboratories), owing to the abundant expression of the coxsackie and adenoviral receptor. Preliminary studies demonstrated adenovirally driven A 2b AR expression in hepatocytes and in the liver of mice injected with AdV ( Figure VII in the onlineonly Data Supplement). Restoration of the A 2b AR in this 
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organ, verified by quantitative polymerase chain reaction expression studies and cAMP measurements, resulted in a decrease in plasma triglycerides and cholesterol levels compared with dKO mice injected with vehicle ( Figure 6A and 6B). The plasma lipid reduction was associated with downregulation of the mRNA and protein levels of ACC and FAS ( Figure 6C-6F ). Adenoviral restoration of the A 2b AR in the liver resulted in a 2-fold increase in cAMP level compared with wild-type livers, signifying receptor overexpression rather than rescue to control levels ( Figure 6G ). To explore the potential therapeutic effect of the A 2b AR on atherosclerosis, we injected ApoE-null mice (with wild-type A 2b AR alleles) intraperitoneally with BAY 60-6583 or vehicle for 12 weeks and then examined plasma lipid levels and atherosclerotic plaque formation. Mice injected with BAY 60-6583 had reduced atherosclerotic plaque formation (Figure 7A and 7B) and circulating plasma lipids ( Figure 7C and 7D) compared with mice injected with vehicle. Administration of BAY 60-6583 to the A 2b AR, ApoE dKO mice had no effect on cholesterol and triglycerides levels, supporting the conclusion that the lipid-lowering effect of BAY 60-6583 in the ApoE KO mice is due to a specific effect on the A 2b AR ( Figure VIIIA and Figure VIIIB in the online-only Data Supplement). These findings point to the therapeutic potential of this ligand and to the need to develop additional A 2b ARselective agonists. BAY 60-6583 injection lowered liver SREBP-1 levels and the levels of ACC and FAS ( Figure 7E  and 7F ), suggesting that this pathway is involved in the mechanism by which the receptor regulates lipid levels. The effect on SREBP-1 was not observed in livers of agonistinjected dKO mice ( Figure VIIIC in the online-only Data Supplement). The liver enzymes aspartate transaminase and alanine transaminase were not significantly affected by BAY 60-6583 injection ( Figure 4A and Figure IVB in the onlineonly Data Supplement). These observations focus attention on the A 2b AR as a therapeutic target for lowering cholesterol and triglycerides levels and ameliorating atherosclerosis.
Discussion
Previous studies have described the A 2b AR as antiinflammatory 8 and protective against kidney ischemia, 38 cardiac reperfusion injury, 39 and restenosis, 18 typically via bone marrow cell signals. Our results assign a novel function to the A 2b AR with respect to atherosclerosis development as a result of a Western diet. We have shown that the A 2b AR is protective against the early stages of atherosclerosis that result from elevated consumption of dietary fat and cholesterol. Elevated cholesterol and triglyceride levels have been associated with an increase in cardiovascular pathology such as atherosclerosis as a result of plaque formation in the arteries. 40 Macrophages play a key role in the process of atherosclerosis in that they sequester oxidized low-density lipoprotein in the subendothelial space and give rise to the so-called fatty streaks that can progress to more complex plaques and form occlusions. A 2b AR bone marrow-derived signals, which originate predominantly from the bone marrow macrophages, did not have an effect on plaque formation. Rather, the role of A 2b AR is in the reduction of liver lipid production and circulation of cholesterol and triglycerides, which mediated the observed effect on plaque development. Interestingly, in similar settings, upon elimination of the A 2a AR, aortic lesions were reduced, which the authors attributed to increased apoptosis of foam cells, resulting in a lower density of foam cells in atherosclerotic lesions. 16 Bone marrow-derived signals from A 2a AR, ApoE dKO mice after transplantation induced early apoptosis of macrophages and consequently reduced the size of atherosclerotic lesions. 16 In contrast, our study shows that in the case of the A 2b AR, its ablation promotes fatty liver formation, an increase in liver and plasma triglycerides and cholesterol, and a consequent augmentation of atherosclerotic plaque formation. Consistent with this finding, elevation of lipid levels is also observed in A 2b AR KO mice with normal ApoE gene expression, indicating that this phenomenon is not dependent on the absence of ApoE.
In an earlier study, we reported the inducibility of the A 2b AR by oxidative stress or inflammation. 41 Exposure to an HFD vastly elevated the level of expression of the liver A 2b AR, which could account for its protective effect against hyperlipidemia, hepatic steatosis, and atherosclerosis; this upregulation of A 2b AR in the liver is also seen in the presence of the ApoE gene after exposure to an HFD and in older mice (Ն28 weeks old) on a regular chow diet (data not shown). Since the pathogenesis of atherosclerosis and augmented lipid synthesis are associated with hypertension and impaired glucose clearance, we measured hemodynamic parameters after an HFD. There was no observable difference in heart rate or blood pressure between the ApoE KO and the A 2b AR, ApoE dKO mice after an HFD ( Table II in the online-only Data Supplement). In addition, glucose clearance in response to glucose overload was similar in control and A 2b AR KO mice under an ApoE KO background (data not shown).
In the context of HFD consumption, elimination of A 2b AR resulted in an increase in liver cholesterol content, liver steatosis, and an increase in plasma cholesterol and triglyceride levels. On a molecular level, elimination of A 2b AR in the liver in vivo caused upregulation of SREBP-1 and its downstream targets, ACC and FAS. Various factors known to affect SREBP-1 might be altered on total elimination of the A 2b AR. However, in primary hepatocytes, there is still a direct influence of A 2b AR signaling on SREBP-1 levels, as shown by direct pharmacological activation or inhibition of A 2b AR.
Although we found that the A 2b AR regulated SREBP-1, there was no effect of A 2b AR elimination on SREBP-2 or its downstream target, HMG CoA reductase, both of which are involved in the control of cholesterol synthesis. Acetyl-CoA is the primary substrate for both cholesterol and fatty acid synthesis, and its increase is associated with elevation in cholesterol production. 42 It is possible, then, that the effect of A 2b AR on cholesterol levels is not achieved by changing HMG CoA reductase levels but rather by affecting its activity or augmentation of the acetyl-CoA pool through the increase in circulating lipids. Interestingly, pharmacological treatments of hepatocyte cell lines did not yield an observable change in SREBP-1 level on A 2b AR stimulation or inhibition. 43 The new role we describe here for the A 2b AR in vivo and in primary hepatocytes is associated with an effect on the SREBP-1c form, which is the predominant transcript in human and mouse livers, rather than SREBP-1a, the major isoform in cell lines. 34 The role of liver A 2b AR in the control of the lipid profile was examined by restoring this receptor in this organ in the context of total A 2b AR KO and by studies in primary hepatocytes. Liver-specific restoration of the receptor led to downregulation of SREBP-1 and of its downstream targets, ACC and FAS and consequently lowered plasma lipid profile. This is consistent with other studies in which deletion or knockdown of SREBP-1 leads to downregulation of lipid synthesis. 44 -46 Prolonged exposure to A 2b AR-specific agonist led not only to a reduction of circulating plasma lipids but also to a decrease in plaque formation. This proposes a new role for the A 2b AR in regulating SREBP-1 levels and in fighting hyperlipidemia and reducing atherosclerosis. 
Conclusion
This study reveals a novel protective role of the A 2b AR with respect to hyperlipidemia, hepatic steatosis, and atherosclerosis induced by elevated dietary fat and cholesterol consumption. Our study is the first to describe the vast upregulation of this liver receptor under HFD and to highlight its importance in regulating triglyceride and cholesterol synthesis. Lipid regulation by A 2b AR is associated with negative regulation of SREBP-1 and its downstream targets ACC and FAS, suggesting that this pathway is at least partially involved in the mechanism by which A 2b AR regulates plasma lipid levels and atherosclerotic plaque formation.
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